EUCTR2005-005122-31-BE进行中（未招募）不适用
Evaluation versus placebo of the effects on heart rate, haemodynamic parameters, safety and tolerability of 5 mg bolus of ivabradine followed by 8-hour infusion of 5 mg of ivabradine, given to patients undergoing a percutaneous coronary intervention following a myocardial infarction with ST segment elevation (STEMI)A pilot, blind, randomised, placebo-controlled, international, multi-centre study.Including the ancillary sub-study to the clinical study protocol - VIVIFY
Institut de Recherches Internationales0 个研究点目标入组 75 人开始时间: 2006年12月18日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Male or female patients,
- •- aged between 40 and 80 years (inclusive),
- •- HR > 80 bpm in sinus rythm,
- •- patients who are undergoing a Percutaneous Coronary Intervention following an acute myocardial infarction with ST segment elevation.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Sick sinus syndrome;
- •- second-degree or third-degree AV block;
- •- trifascicular block and PR > 240 ms;
- •- hypertrophic cardiomyopathy, severe valvular disease, or severe congenital heart disease;
- •- suspected aortic dissection;
- •- known relevant electrolyte disorders.
研究者
相似试验
进行中（未招募）
不适用
Evaluation versus placebo of the effects on heart rate, haemodynamic parameters, safety and tolerability of 5 mg bolus of ivabradine followed by 8-hour infusion at the dose of 5 mg of ivabradine given to patients undergoing a percutaneous coronary intervention following a myocardial infarction with ST segment elevation - VIVIFYAcute Myocardial InfarctionEUCTR2005-005122-31-DEInstitut de Recherches Internationales75
招募中
2 期
Comparison of cardiovascular effects of ropevacaine and lidocaine with epinephrine in implant surgeryHemodynamic effects.IRCT20211127053190N1Shahid Beheshti University of Medical Sciences18
进行中（未招募）
不适用
Effect of ivabradine versus placebo on cardiac function and on capacity to perform exercise in patients suffering from diastolic heart failure.Heart failure with preserved left ventricular ejection fractionMedDRA version: 18.1Level: LLTClassification code 10008908Term: Chronic heart failureSystem Organ Class: 100000004849EUCTR2012-002742-20-PTInstitut de Recherches Internationales Servier400
进行中（未招募）
1 期
Effect of ivabradine versus placebo on cardiac function and on capacity to perform exercise in patients suffering from diastolic heart failure.Heart failure with preserved left ventricular ejection fractionMedDRA version: 18.1Level: LLTClassification code 10008908Term: Chronic heart failureSystem Organ Class: 100000004849EUCTR2012-002742-20-DEInstitut de Recherches Internationales Servier400
进行中（未招募）
1 期
Effect of ivabradine versus placebo on cardiac function and on capacity to perform exercise in patients suffering from diastolic heart failure.Heart failure with preserved left ventricular ejection fractionMedDRA version: 17.0Level: LLTClassification code 10008908Term: Chronic heart failureSystem Organ Class: 100000004849EUCTR2012-002742-20-ATInstitut de Recherches Internationales Servier400